Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Aug;83(15):7366-74.
doi: 10.1128/JVI.00191-09. Epub 2009 May 6.

Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes

Yaron Rotman  1 , T Jake Liang
Affiliations
Review

Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes

Yaron Rotman et al. J Virol. 2009 Aug.
No abstract available

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Mechanism of HCV-HIV interaction. HIV does not infect hepatocytes but can influence the outcome of HCV infection through infection of CD4+ T cells and the effects of gp120 protein on hepatocytes and other immune cells via its interaction with chemokine receptors. HIV infection of gut-associated lymphoid tissue leads to increased LPS uptake, resulting in HSC activation and increased fibrosis. Possible HIV infection of HSCs can also lead to HSC activation. The effects of HCV on immune cells may affect the outcome of HIV infection. DC, dendritic cell; MHC, major histocompatibility complex. Dashed arrows represent the effect of viral envelope proteins or possible infection; solid arrows represent productive infection.
See this image and copyright information in PMC

References

    1. Albert, M. L., J. Decalf, and S. Pol. 2008. Plasmacytoid dendritic cells move down on the list of suspects: in search of the immune pathogenesis of chronic hepatitis C. J. Hepatol. 491069-1078. - PubMed
    1. Alter, M. J. 2006. Epidemiology of viral hepatitis and HIV co-infection. J. Hepatol. 44S6-9. - PubMed
    1. Antonucci, G., E. Girardi, A. Cozzi-Lepri, M. R. Capobianchi, A. De Luca, M. Puoti, E. Petrelli, G. Carnevale, G. Rizzardini, P. A. Grossi, P. Vigano, M. C. Moioli, F. Carletti, M. Solmone, G. Ippolito, and A. D. Monforte. 2005. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals. Clin. Infect. Dis. 40e101-e109. - PubMed
    1. Antonucci, G., D. Goletti, S. Lanini, E. Girardi, and O. Loiacono. 2003. HIV/HCV co-infection: putting the pieces of the puzzle together. Cell Death Differ. 10S25-S26. - PubMed
    1. Aranzabal, L., J. L. Casado, J. Moya, C. Quereda, S. Diz, A. Moreno, L. Moreno, A. Antela, M. J. Perez-Elias, F. Dronda, A. Marin, F. Hernandez-Ranz, A. Moreno, and S. Moreno. 2005. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection. Clin. Infect. Dis. 40588-593. - PubMed